Eastern Asia is a prime location for the study of intracontinental tectono‐magmatic activity. For instance, the origin of widespread intraplate volcanism has been one of the most debated aspects of East Asian geological activity. Measurements of attenuation of teleseismic phases may provide additional constraints on the source regions of volcanism by sampling the upper mantle. This study uses data from three seismic arrays to constrain lateral variations in teleseismic P wave attenuation beneath the Central Asian Orogenic Belt and the North China Craton. We invert relative observations of attenuation for a 2‐D map of variations in attenuation along with data and model uncertainties by applying a Hierarchical Bayesian method. As expected, low attenuation is observed beneath the Ordos block. High attenuation is observed beneath most of the volcanoes (e.g., the Middle Gobi volcano, the Bus Obo volcano, and the Datong volcano) in the study area, and estimated asthenospheric Qp values span from 95 to 200. These values are within the range of globally average asthenosphere. We infer that these volcanoes may tap melt from ambient asthenosphere and occur where the lithosphere is thin, which is consistent with previous petrologic studies. More complex mantle drivers of volcanism are not rejected but are not needed to explain eruptions in this area. In contrast, at the Xilinhot‐Abaga volcanic site, the observed low attenuation (as low as beneath the Ordos block) excludes a typical shallow melting column. Fluids from the subducted Pacific plate may initiate the deep melting and would be consistent with petrological constraints.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.